Posted by Michael Wonder on 16 Mar 2017
NICE gets go-ahead to fast-track more drug approvals
15 March 2017 - Patients will benefit from access to the most cost-effective treatments nearly 5 months faster after changes to the NICE drug evaluation process were approved.
The changes will see the introduction of a new fast-track option for appraising treatments which offer exceptional value for money. The aim is for them to be available to patients a month after they are licensed.
The fast track appraisals, which will be rolled out to more drugs in time, are part of several changes to NICE processes approved by the Board on Wednesday.
